Bruce Neal's Publications

• Relative and Absolute Risk Reductions in Cardiovascular and Kidney Outcomes With Canagliflozin Across KDIGO Risk Categories: Findings From the CANVAS Program

  Journal articles

  2021

  American Journal of Kidney Diseases

• Ultra-low-dose quadruple combination blood pressurelowering therapy in patients with hypertension: The QUARTET randomized controlled trial protocol

  Journal articles

  2021

  American Heart Journal

• Sodium-glucose co-transporter-2 inhibition and ocular outcomes in patients with type 2 diabetes: A systematic review and meta-analysis

  Journal articles

  2021

  Diabetes, Obesity and Metabolism

• KidneyIntelX as an Enrichment Tool for Clinical Trials in Early Diabetic Kidney Disease

  Journal articles

  2021

  Journal of the American Society of Nephrology

• Circulating Metabolites to Predict Renal Outcomes in CANVAS Type 2 Diabetes Mellitus Population

  Journal articles

  2021

  Journal of the American Society of Nephrology

• Corrigendum

  Journal articles

  2021

  ESC Heart Failure

• Canagliflozin and Cardiovascular Outcomes in Patients With and Without Peripheral Artery Disease At Baseline: Data from the CANVAS Program and CREDENCE Trials

  Journal articles

  2021

  Heart Lung and Circulation

• HOW MANY ADDITIONAL PHYSICIANS ARE NEEDED FOR HYPERTENSION TREATMENT IN INDIA?

  Conference Abstracts

  2021

  Journal of Hypertension

• Canagliflozin Reduces All-cause Hospitalization in Patients with Type 2 Diabetes Mellitus

  Conference Abstracts

  2021

  Metabolism

• Availability, Formulation, Labeling, and Price of Low-sodium Salt Worldwide: Environmental Scan (Preprint)

  Journal articles

  2021

  JMIR Public Health and Surveillance

• Estimating the potential impact of Australias reformulation programme on households sodium purchases

  Journal articles

  2021

  BMJ Nutrition, Prevention & Health

• Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study

  Journal articles

  2020

  Journal of the American College of Cardiology

• Effects of canagliflozin in patients with baseline eGFR <30 mlmin per 1.73 msup2sup: Subgroup analysis of the randomized CREDENCE trial

  Journal articles

  2020

  Clinical Journal of the American Society of Nephrology

• Correction to: Contribution of major food companies and their products to household dietary sodium purchases in Australia (International Journal of Behavioral Nutrition and Physical Activity, (2020), 17, 1, (81), 10.1186s12966-020-00982-z)

  Journal articles

  2020

  International Journal of Behavioral Nutrition and Physical Activity

• The impact of voluntary front-of-pack nutrition labelling on packaged food reformulation: A difference-in-differences analysis of the Australasian Health Star Rating scheme

  Journal articles

  2020

  PLoS Medicine

• Effects of Canagliflozin on Amino-Terminal ProB-Type Natriuretic Peptide: Implications for Cardiovascular Risk Reduction

  Journal articles

  2020

  Journal of the American College of Cardiology

• Seventeen-year associations between diet quality defined by the health star rating and mortality in australians: The australian diabetes, obesity and lifestyle study (ausdiab)

  Journal articles

  2020

  Current Developments in Nutrition

• Effects of canagliflozin on anaemia in patients with type 2 diabetes and chronic kidney disease: a post-hoc analysis from the CREDENCE trial

  Journal articles

  2020

  The Lancet Diabetes and Endocrinology

• Effects of canagliflozin on initiation of insulin and other antihyperglycaemic agents in the CANVAS Program

  Journal articles

  2020

  Diabetes, Obesity and Metabolism

• The effects of combination canagliflozin and glucagon-like peptide-1 receptor agonist therapy on intermediate markers of cardiovascular risk in the CANVAS program

  Journal articles

  2020

  International Journal of Cardiology

• Different eGFR decline thresholds and renal effects of canagliflozin: Data from the CANVAS program

  Journal articles

  2020

  Journal of the American Society of Nephrology

• The effects of canagliflozin on heart failure and cardiovascular death by baseline participant characteristics: analysis of the CREDENCE trial

  Conference Abstracts

  2020

  DIABETOLOGIA

• Acute declines in eGFR during treatment with canagliflozin and its implications for clinical practice: insights from CREDENCE

  Conference Abstracts

  2020

  DIABETOLOGIA

• Prospective associations of four nutrient profiles with weigh gain, overweight and obesity risk

  Journal articles

  2020

  European Journal of Public Health

• Estimated 24-Hour Urinary Sodium Excretion and Incident Cardiovascular Disease and Mortality among 398628 Individuals in UK Biobank

  Journal articles

  2020

  Hypertension

• Mediators of the effects of canagliflozin on kidney protection in patients with type 2 diabetes

  Journal articles

  2020

  Kidney International